Regel Therapeutics

Developer of targeted gene therapies for genetic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups17 employees language regeltherapeutics.com

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 182 times.

YearFilings
20232
20244
20253
20261

Social engagement

Social engagement: 6.3K social following, 1 post in the last 12 months — above the industry median.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon